Ascendis Pharma
ASND
ASND
211 hedge funds and large institutions have $8.78B invested in Ascendis Pharma in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 85 increasing their positions, 65 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
10% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 39
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
64% less call options, than puts
Call options by funds: $11.9M | Put options by funds: $32.7M
Holders
211
Holding in Top 10
14
Calls
$11.9M
Puts
$32.7M
Top Buyers
| 1 | +$132M | |
| 2 | +$104M | |
| 3 | +$70.7M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$55.4M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$54.3M |
Top Sellers
| 1 | -$97.5M | |
| 2 | -$76.7M | |
| 3 | -$74.8M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$72.7M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$59.4M |